This strong expression of TNFAIP3 found in lesional psoriatic skin has been posited to inhibit the NF-κB pathway; however, a strong expression of NF-κB was observed [49], suggesting that TNFAIP3 is disabled or dysfunctional in patients with psoriasis [50]. Here, TNFAIP3 is linked to psoriasis.